05.16.11
Elizabeth Thomas has been appointed vice president and general manager of ICON’s Bioanalytical Operations in Manchester, UK. Ms. Thomas has more than 30 years of experience in bioanalysis. She joins the company from AstraZeneca, where she was global discipline leader, Bioanalysis. In this role she led the global Bioanalysis group and the company’s bioanalytical and biomarker lab in Manchester, UK. Prior to AstraZeneca, Ms. Thomas managed the bioanalytical groups at both Quintiles and Covance.
Brian O’Dwyer, vice president Bioanalytical Development, ICON Development Solutions, said, “We are pleased to welcome Liz and the significant commercial, operational and strategic experience she brings to our bioanalytical sciences business. While Liz’s principal focus and responsibility will be the general management of our UK laboratory operations, she will also play a major role in harmonizing and expanding our bioanalytical capabilities globally.”
Additionally, ICON has appointed of Dr. Tony Upton associate director of Immunoassay Services, EU. Dr. Upton joins the company from Emergent Ltd., where he managed the company’s internal live and protein based vaccine lab and oversaw external contract laboratories supporting Emergent’s development programs.
Brian O’Dwyer, vice president Bioanalytical Development, ICON Development Solutions, said, “We are pleased to welcome Liz and the significant commercial, operational and strategic experience she brings to our bioanalytical sciences business. While Liz’s principal focus and responsibility will be the general management of our UK laboratory operations, she will also play a major role in harmonizing and expanding our bioanalytical capabilities globally.”
Additionally, ICON has appointed of Dr. Tony Upton associate director of Immunoassay Services, EU. Dr. Upton joins the company from Emergent Ltd., where he managed the company’s internal live and protein based vaccine lab and oversaw external contract laboratories supporting Emergent’s development programs.